Browse Related Topics For:

Biologics

136
FDA
136
Pharmaceutical Industry
105
Biosimilars
77
Prescription Drugs
72
Patents
69
BPCIA
64
Pharmaceutical Patents
43
Patent Infringement
40
Sandoz v Amgen
39
Amgen
39
Patent Litigation
32
Sandoz
31
Medical Devices
25
CMS
24
Healthcare
22
Medicare
22
Trans-Pacific Partnership
21
Generic Drugs
21
Patent Dance
18
Affordable Care Act
17
Medicaid
17
Popular
16
Biologics Price Competition and Innovation Act of 2009
16
Commercial Marketing
16
Notice Requirements
15
FDA Approval
15
SCOTUS
14
Biotechnology
14
Inter Partes Review (IPR) Proceeding
13
Draft Guidance
13
Preliminary Injunctions
12
Appeals
11
Life Sciences
11
Sunshine Act
10
Comment Period
10
Health Care Providers
10
Hospira
9
aBLA
9
Apotex
9
Declaratory Judgments
9
FDCA
9
FTC
9
Manufacturers
9
Physicians
8
Drug Pricing
8
GPOs
8
Labeling
8
Patent-Eligible Subject Matter
8
Proposed Legislation
8
Public Health Service Act
8
Trade Agreements
7
ANDA
7
Clinical Trials
7
EU
7
Hatch-Waxman
7
Innovation
7
Medical Supplies
7
Medicare Part B
7
Payment Records
7
Product Labels
7
Proposed Regulation
6
CHIP
6
Genentech
6
Intellectual Property Protection
6
Legislative Agendas
6
Patent Applications
6
Patent Trial and Appeal Board
5
Certiorari
5
Covered Recipients
5
Health Insurance
5
Hospitals
5
Long Term Care Facilities
5
Pfizer
5
Pharmacies
5
PHSA
5
Physician Medicare Reimbursements
5
Product Exclusivity
5
Reporting Requirements
5
Research and Development
5
Skilled Nursing Facility
5
Solicitor General
5
Trump Administration
5
USPTO
5
Vaccinations
5
World Health Organization
4
Barack Obama
4
Cancer
4
Department of Veterans Affairs
4
Exclusivity
4
Final Rules
4
GAO
4
Genetic Materials
4
HELP
4
Injunctive Relief
4
Licensing Rules
4
Medical Research
4
Myriad
4
New Legislation
4
Preemption
4
Public Comment
4
REMS
4
Teaching Hospitals
3
ACOs
3
Applicable Manufacturers
3
Australia
3
Automotive Industry
3
Canada
3
Competition
3
Continuing Medical Education
3
Declaratory Relief
3
Disclosure Requirements
3
DOJ
3
Drug Safety
3
Fast Track Process
3
FD&C Act
3
Federal Budget
3
Federal Register
3
Final Guidance
3
Guidance Update
3
Health Canada
3
Healthcare Reform
3
HHS
3
Hospice
3
Inpatient Rehab Facilities
3
License Applications
3
Medicare Access and CHIP Reauthorization (MACRA)
3
Medicare Advantage
3
Medicare Part D
3
Merck
3
Mylan Pharmaceuticals
3
NAFTA
3
New Guidance
3
NIH
3
Obviousness
3
Patent Invalidity
3
Petition for Writ of Certiorari
3
Pharmacist
3
Physician Payments
3
Prior Art
3
Purple Book
3
Remedies
3
Summary Judgment
3
TRIPS Agreement
3
Veterans
2
21st Century Cures Initiative
2
AbbVie
2
Alternative Payment Models (APM)
2
Amarin
2
AMP v Myriad
2
Animal Drugs
2
Anti-Competitive
2
Biopharmaceutical
2
CADTH
2
CDC
2
CETA
2
CGMP
2
Citizen Petitions
2
Common Ownership
2
Confidential Information
2
Conversion
2
CVS
2
Data Protection
2
Diagnostic Tests
2
Dismissals
2
Dispute Resolution
2
EHR
2
Eli Lilly
2
EPA
2
Expert Testimony
2
Exports
2
FFDCA
2
First Amendment
2
Genzyme
2
GM/Synbio Algae Project
2
HCPCS
2
Health Information Technologies
2
Home Healthcare Workers
2
HRSA
2
Imports
2
Inpatient Prospective Payment System (IPPS)
2
Intellectual Property Litigation
2
Interchangeability
2
International Harmonization
2
Investigational New Drug procedures (IND)
2
IRS
2
ITC
2
Janssen Pharmaceuticals
2
Leave to Appeal
2
Medical Malpractice
2
Mergers
2
Monopolization
2
Native American Issues
2
Obama Administration
2
OIG
2
OMB
2
Opioid
2
Pending Legislation
2
Personal Jurisdiction
2
PHRMA
2
PMNOC Regulations
2
Post-Grant Review
2
Psychiatric Hospitals
2
Public Health Insurance Marketplace
2
Public Hearing
2
Qualified Health Plans
2
Regulatory Standards
2
Right to Try
2
SAMHSA
2
Sanofi
2
Scientific Evidence
2
Settlement
2
Supreme Court of Canada
2
Telehealth
2
Teva Pharmaceuticals
2
Trade Unions
2
Trademarks
2
Transfers of Value
2
Transparency
2
Unfair Competition
2
Unjust Enrichment
2
Vacated
2
Value-Based Purchasing
2
Wage and Hour
2
Zika
1
1099s
1
510(k) RTA
1
Abuse of Process
1
Acquisitions
1
Administrative Proceedings
1
Admissible Evidence
1
Admissions
1
Advertising
1
Advisory Committee
1
All Writs Act
1
Allergan Inc
1
America Invents Act
1
Amgen v Sandoz
1
Amicus Briefs
1
Animal Patents
1
Anticipation
1
Anticompetitive Agreements
1
Antitrust Investigations
1
Antitrust Violations
1
Applications
1
Arbitration
1
Asbestos
1
Asbestos Litigation
1
Assisted Living Facility
1
AstraZeneca
1
Attorney Generals
1
Australian Patent Office
1
Bad Debt
1
Bayer
1
Bayh-Dole Act
1
Big Data
1
Biobased Chemicals
1
Biogen Idec
1
Bipartisan Budget
1
BRCA
1
Bristol-Myers Squibb
1
Burden of Proof
1
Cadillac Tax
1
Calculation of Damages
1
Caregivers
1
CCIIO
1
Celltrion
1
Center for Drug Evaluation and Research (CDER)
1
Chamber of Commerce
1
Chemicals
1
China
1
Chrysler
1
CLIA
1
Clinical Laboratory Testing
1
CLS Bank v Alice Corp
1
CME
1
Compensatory Awards
1
Competition Authorities
1
Congressional Committees
1
Consent
1
Constitutional Challenges
1
Continuing Care Retirement Communities
1
Continuing Resolution
1
Controlled Substances
1
Controlled Substances Act
1
Copyright
1
Corporate Counsel
1
Country of Origin
1
Covered Business Method Patents
1
Covered Entities
1
Covered Products
1
CREATE Act
1
Cross Motions
1
Cross-Border Transactions
1
Cross-Complaints
1
Currency Manipulation
1
Cybersecurity
1
DaimlerAG
1
DaimlerChrysler v Bauman
1
Dairy Farmers
1
Data Collection
1
Databases
1
DEA
1
Decision-Making Process
1
Deficit Reduction
1
Design Defects
1
Disclosure
1
Discovery
1
Diversity Jurisdiction
1
Double Patent
1
DQSA
1
Drug Approvals
1
Drug Compounding
1
Drug Treatment
1
DSCSA
1
DSRIP
1
E-Commerce
1
Electronic Medical Records
1
Electronic Records
1
Employer Group Health Plans
1
Employer Mandates
1
Employer Payment Plans
1
En Banc Review
1
Enforcement
1
Environmental Policies
1
ERISA
1
European Commission
1
European Patent Office
1
Evidence
1
Exclusive Dealing Agreements
1
Exclusive Licenses
1
Exclusive Use
1
Exclusivity Clauses
1
Extrapolation
1
Failure To Warn
1
FDASIA
1
Filing Deadlines
1
Financial Institutions
1
Food and Drug Modernization Act
1
Food Manufacturers
1
Ford Motor
1
Foreign Manufacturers
1
Fraud and Abuse
1
Fraudulent Joinder
1
Free Speech
1
FTC v Actavis
1
GATT
1
General Jurisdiction
1
General Motors
1
General Wellness Devices
1
Generic
1
Genome Project
1
Global Economy
1
Government Studies
1
Governor Brown
1
Governor Malloy
1
HCEI
1
Health IT
1
Health Savings Accounts
1
Healthcare Facilities
1
Healthcare Fraud
1
Healthcare.gov
1
Hillary Clinton
1
Home Health Agencies
1
Home Health Care
1
Human Trafficking
1
Individual Mandate
1
Information Sharing
1
Informed Consent
1
Inherent Disclosure Doctrine
1
Injunctions
1
Innovation Act
1
Innovator Liability
1
Inpatient Quality Reporting
1
Interlocutory Appeals
1
Internet
1
Investigations
1
IP License
1
Ireland
1
Irreparable Harm
1
Johns Hopkins
1
Johnson & Johnson
1
Joinder
1
Laboratories
1
Licenses
1
Long-Term Care
1
Manufacturing Defects
1
Marketing
1
Marketing Authorization Application
1
Mayo v. Prometheus
1
Meaningful Use
1
Medicaid Expansion
1
Medical Device Tax
1
Medical Liability
1
Medical Licensure Compact
1
Medical Reimbursement
1
Medicines and Healthcare Products Regulatory Agency (MHRA)
1
MedPAC
1
Minimum Wage
1
Mootness
1
Motion for Leave
1
Motion to Compel
1
Motion to Dismiss
1
Motion To Stay
1
Motion To Strike
1
Motion to Terminate
1
Negotiations
1
New Regulations
1
Novartis
1
Nurses
1
Nursing Homes
1
Off-Label Promotion
1
Off-Label Use
1
Ombudsman
1
Oral Argument
1
Orange Book
1
Organ Donation
1
Orphan Drugs
1
OSTP
1
OTC
1
Out of Network Provider
1
Out-of-Pocket Expenses
1
Outsourcing
1
Over-the-Counter Sales
1
Patent Filings
1
Patent Prosecution
1
Patent Reform
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent Terms
1
Patent Trolls
1
Patent Validity
1
Patented Medicine Prices Review Board (PMPRB)
1
Patient Rights
1
Patient Safety
1
Patient Self-Referral
1
PCORI
1
Penalties
1
Permanent Injunctions
1
Personalized Medicine
1
Physician Fee Schedule
1
Physician Ownership
1
Physician SGR Formula
1
Physician-Assisted Suicide
1
Plant Patents
1
Political Debates
1
Post-Market Approval
1
Premarket Approval Applications
1
Prescription Drug Coverage
1
Press Releases
1
Private Right of Action
1
Product Defects
1
Product of Nature Doctrine
1
Professional Conferences
1
Proposed Rules
1
Provider Payments
1
Public Health
1
Public Meetings
1
Public Policy
1
Public Safety
1
Quality Control Plan
1
Real Party in Interest
1
Regulatory Oversight
1
Repeal
1
Research Funding
1
Rural Areas
1
Rural Health Care Program
1
Safe Harbors
1
Safety Precautions
1
Samsung
1
Sanofi-Aventis
1
Scientific Research
1
Secretary of HHS
1
Section 337
1
Section 340B
1
SFDA
1
Sherman Act
1
Social Media
1
Software
1
Specialty Healthcare
1
Specific Jurisdiction
1
Standard of Care
1
Standing
1
Stark Law
1
State Budgets
1
State Health Insurance Exchanges
1
Statute of Limitations
1
Stem cells
1
STRONG Patents Act
1
Tariffs
1
Tax Credits
1
Technology
1
Telecommunications
1
The Common Rule
1
The Enlarged Board of Appeals
1
The Patent Act
1
Third-Party
1
Tobacco Litigation
1
Tobacco Regulations
1
Tolling
1
Toxic Exposure
1
Toxic Substances Control Act (TSCA)
1
Trade Policy
1
Trade Promotion Agreements
1
Trade Promotion Authority
1
Trade Relations
1
Trade Secrets
1
Trademark Infringement
1
Traumatic Brain Injuries
1
Treaties
1
U.S. House
1
UK
1
Unfair Labor Practices
1
Unions
1
US Trade Policies
1
USDA
1
Utility Patents
1
Warning Labels
1
Webinars
1
Websites
1
Wrongful Death
1
WTO
1
Young Lawyers